Medicare Enrolled

Dr. John Cozart, MD

Optician · Texarkana, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1920 MOORES LN, Texarkana, TX 75503
9037928030
In practice since 2005 (20 years)
NPI: 1952309262 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cozart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cozart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cozart

Dr. John Cozart is an optician in Texarkana, TX, with 20 years in practice. Based on federal Medicare data, Dr. Cozart performed 3,464 Medicare services across 1,562 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cozart received a total of $5,783 from 30 pharmaceutical and/or device companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cozart is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 19% volume in TX$ $5,783 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,464
Medicare services
Top 19% in TX for optician
1,562
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~173 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Chronic care management, additional 20 min/month1,329$37$92
Chronic care management, first 20 min/month782$48$122
Colonoscopy with biopsy263$107$804
New patient office visit (45-59 min)239$117$261
Office visit, established patient (30-39 min)213$88$156
Upper GI endoscopy with biopsy108$56$700
Remote patient monitoring management, 20 min/month89$38$94
Tying of multiple internal hemorrhoid groups77$297$742
Removal of polyps or growths of large bowel using an endoscope with mechanical snare68$168$1,017
Remote patient monitoring device, 30 days65$38$95
Initial hospital admission, moderate complexity44$100$220
Insertion of guide wire with dilation of esophagus using a flexible endoscope39$110$750
Hospital follow-up visit, moderate complexity36$59$109
Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets22$258$657
Initial hospital admission, high complexity22$136$306
Tying of single internal hemorrhoid group17$247$610
Hospital follow-up visit, low complexity14$33$74
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope13$80$547
Injection beneath lining of large bowel using a flexible endoscope12$10$678
Study of rectum sensitivity and function12$212$589
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,783
Total received (2018-2024)
Avg $826/year across 7 years
Top 24% in TX for optician
30
Companies
413
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,767 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$539
2023
$512
2022
$960
2021
$1,642
2020
$670
2019
$806
2018
$655

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$1,015
AbbVie Inc.
$844
Janssen Biotech, Inc.
$766
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$620
ABBVIE INC.
$599
Takeda Pharmaceuticals U.S.A., Inc.
$370
PFIZER INC.
$348
AbbVie, Inc.
$307
Allergan Inc.
$177
Celgene Corporation
$89
Braintree Laboratories, Inc.
$79
RedHill Biopharma Inc.
$70
Ironwood Pharmaceuticals, Inc
$67
EVOKE PHARMA, INC.
$50
Mauna Kea Technologies, Inc.
$39
Boston Scientific Corporation
$35
GENZYME CORPORATION
$32
Amgen Inc.
$31
Merck Sharp & Dohme Corporation
$27
INTERCEPT PHARMACEUTICALS, INC.
$26
Merck Sharp & Dohme LLC
$26
UCB, Inc.
$25
Nestle HealthCare Nutrition Inc.
$22
Myriad Genetic Laboratories, Inc.
$21
Lilly USA, LLC
$20
Medtronic, Inc.
$19
Prometheus Laboratories Inc.
$18
Madrigal Pharmaceuticals
$16
Allergan, Inc.
$12
Organon LLC
$12
Top 3 companies account for 45.4% of total payments
Associated products mentioned in payments ›
AVSOLA · Amitiza · BYVALSON · CAPTIVATOR COLD · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · Entyvio · GI Genius · GIMOTI · HUMIRA · Humira · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · OCALIVA · OMVOH · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUPREP · SUPREP BOWEL PREP · SUTAB · TRULANCE · Talicia · UCERIS TABLETS · VIBERZI · XELJANZ · XIFAXAN · ZENPEP · ZEPATIER · ZEPOSIA · myRisk · talicia
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $167 per 100 Medicare services performed
Looking for a optician in Texarkana?
Compare opticians in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
24
Per 100K population
26.0
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cozart is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cozart experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Cozart performed 1,329 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cozart receive payments from pharmaceutical companies?
Yes. Dr. Cozart received a total of $5,783 from 30 companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cozart's costs compare to other opticians in Texarkana?
Dr. Cozart's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cozart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →